(Press-News.org) The first-of-its-kind in-depth bacterial evolutionary map could pave the way for the development of precision treatments for certain antibiotic-resistant infections, such as urinary tract infections.
Researchers at the Wellcome Sanger Institute, the University of Oslo, UiT The Arctic University of Norway, and their collaborators, have developed a new way of using large-scale long-read sequencing data to investigate circular genetic structures called plasmids in the most commonly studied microbe, Escherichia coli (E. coli). Through this, the team were able to track the flow of gene exchange, identify some of the barriers preventing this, and trace outbreaks of different E. coli strains to specific plasmids going back approximately 300 years.
The study, published today (3 April) in Nature Communications, also uncovered a plasmid found in multiple strains of E. coli that allows them to produce a toxin to kill other closely related bacteria, which could help inform future therapies for bacterial infections.
This high-resolution resource allows the scientific community to investigate E. coli at a level which has not been previously possible, providing information that shows how plasmids co-evolve with E. coli strains. By being able to understand and track which plasmids provide E. coli strains with certain traits, it could be possible to target these directly. This could minimise the need for broad-spectrum antibiotic use, and in turn, lower the spread of treatment-resistant bacterial infections.
Additionally, researchers suggest that if a strain that is less dangerous to humans can naturally outcompete a more dangerous strain, it could be introduced to help manage human health more holistically.
Bacteria are often in competition with each other, fighting for the same habitable landscape, which in the case of E. coli, is the human gut. Most strains of E. coli are harmless; however, if the bacterium gets into the bloodstream due to a weakened immune system, it can cause infection, which can range from mild to life-threatening.
While it often feels like the fight is with humans, E. coli bacteria are mostly competing with other strains for resources. It is this competition that leads to genetic adaptation, such as antibiotic resistance, which will help them survive in certain environments.
Bacteria are able to transfer genetic material, and therefore, certain traits via plasmids, which are circular pieces of DNA. Plasmids often carry genes for virulence, survival, or antibiotic resistance, improving the bacterium's fitness. Multiple plasmids are often found in bacterial cells, and due to their complex genetic composition and ability to share genes with the host cell chromosome, plasmids are incredibly difficult to track.
In this latest study, Sanger Institute researchers and their collaborators used long-read sequencing to create 4,485 plasmid genomes from over 2,000 E. coli bloodstream samples, all collected over 16 years in Norway1. From these newly-created genomes, they were able to map the plasmids linked to 216 different strains of E. coli, including the four most common strains in the UK.
Additionally, the team created a 2D-map showing where genetic material had been transferred horizontally between strains. This allowed them to map the co-evolution of plasmids and E. coli strains back 300 years, illustrating that this is a highly conserved and useful method of genetic transfer. By unravelling the evolution of plasmids, the team were able to connect earlier global outbreaks of particular strains with the plasmids responsible and understand more about the factors that cause certain strains to spread, tracking those with pandemic-causing abilities.
The researchers were also able to identify certain traits that tend not to be compatible. For example, multi-drug resistance to antibiotics and the ability to produce a substance that kills other strains, known as bacteriocin, are not found in the same bacterial strains. Using extensive laboratory experiments, the team were able to verify that those carrying the most successful bacteriocin-encoding genes were able to efficiently inhibit all non-carriers, including the top four most common E. coli strains circulating in the UK. Importantly, the inhibition was effective against all multi-drug resistant strains in the sample, suggesting that further research into these bacteriocins could lead to new ways of treating treatment-resistant bacterial infections in the future.
This evolutionary map is a vital resource for the research community and paves the way for new precision treatments that could target specific plasmids. Additionally, future studies could use this resource to further understand the factors and spread of strains that are more harmful to humans, possibly predicting outbreaks of bacterial infections and helping inform new ways to limit them.
Dr Sergio Arredondo-Alonso, co-first author previously at the University of Oslo, said: “Our work unravels the evolution of E. coli plasmids. From this, we’ve started to uncover what traits can be found together, and what can’t, such as antimicrobial resistance and the ability to create bacteriocin. The discovery of how the bacteriocin-producing ability is distributed among E. coli also highlights the different approaches that strains take to outcompete their rivals. Understanding all the factors in E. coli’s warfare adaptations could be used to inform new ways to limit or prevent the spread of unwanted bacterial strains.”
Professor Pål Johnsen, co-senior author at the UiT The Arctic University of Norway, said: “Bacterial evolution and adaptation often depend on plasmids to support the transfer of genes, and are shaped by environmental factors. Our evolutionary map enables us to start exploring this on a level that has not been possible before, by finally filling in the gaps of plasmid evolution over decades and centuries and providing a way of linking this to what was happening in the world at the time. We have created a new resource to tackle antimicrobial-resistant E. coli which could inform new ways to help stop these strains from spreading.”
Professor Jukka Corander, co-senior author at the Wellcome Sanger Institute and the University of Oslo, said: “This is one of the most exciting research projects I’ve led. It has created a vital resource that I hope supports the wider scientific community to uncover new ways to help tackle bloodstream infections, especially those that are resistant to treatment. By mapping the evolution of plasmids, this resource can help us understand the mechanisms of gene transfer and target the plasmids which carry genetic traits that are most harmful to humans. In the future, this could help develop precision therapies that would reduce the need for wide-spectrum antibiotics, which in turn, could lessen the spread of drug-resistant bacteria.”
ENDS
Contact details:
Rachael Smith
Press Office
Wellcome Sanger Institute
Cambridge, CB10 1SA
07827979492 / 07748379849
Email: press.office@sanger.ac.uk
Notes to Editors:
The samples used were from the unique Norwegian epidemiological longitudinal collection (NORM). This was a nationwide Norwegian genomic surveillance programme tracking resistant microbes which ran from 2002 to 2017 and contains 3,245 E. coli bloodstream infection isolates. Information including the laboratory, date, and antimicrobial susceptibility profile was reported for each isolate. https://www.vetinst.no/en/surveillance-programmes
Publication:
S. Arredondo-Alonso, A. K. Pöntinen, J. Alves Gama, et al. (2025) Plasmid-driven strategies for clone success in Escherichia coli. Nature Communications. DOI: 10.1038/s41467-025-57940-1
Funding:
The research was funded by the Trond Mohn Foundation, the European Union's Horizon 2020 research and innovation programme, Marie Skłodowska-Curie Actions, and the European Research Council. A full acknowledgement list can be found in the publication.
Selected websites:
The Wellcome Sanger Institute
The Wellcome Sanger Institute is a world leader in genomics research. We apply and explore genomic technologies at scale to advance understanding of biology and improve health. Making discoveries not easily made elsewhere, our research delivers insights across health, disease, evolution and pathogen biology. We are open and collaborative; our data, results, tools, technologies and training are freely shared across the globe to advance science.
Funded by Wellcome, we have the freedom to think long-term and push the boundaries of genomics. We take on the challenges of applying our research to the real world, where we aim to bring benefit to people and society.
Find out more at www.sanger.ac.uk or follow us on Twitter, Instagram, Facebook, LinkedIn and on our Blog.
About Wellcome
Wellcome supports science to solve the urgent health challenges facing everyone. We support discovery research into life, health and wellbeing, and we’re taking on three worldwide health challenges: mental health, infectious disease and climate and health. https://wellcome.org/
END
Precision medicine could be possible in the fight against antibiotic resistance
2025-04-03
ELSE PRESS RELEASES FROM THIS DATE:
Researchers at the Lewis Katz School of Medicine at Temple University identify new targeted approach to protect neurons against degeneration
2025-04-03
(Philadelphia, PA) – Neurodegenerative conditions such as Parkinson’s disease and Alzheimer’s involve progressive neuronal loss due to disease-induced damage. An enzyme known as dual leucine-zipper kinase (DLK) plays a key role in this process, telling neurons that are damaged or unhealthy when they should cut their losses and self-destruct. Hence, sparing neurons from DLK is an attractive therapeutic strategy that could slow disease progression.
Past attempts to inhibit DLK’s action in human patients, however, led to unexpected side effects affecting the nervous system, suggesting that DLK ...
Western diet causes inflammation, traditional African food protects
2025-04-03
A switch of just two weeks from a traditional African diet to a Western diet causes inflammation, reduces the immune response to pathogens, and activates processes associated with lifestyle diseases. Conversely, an African diet rich in vegetables, fiber, and fermented foods has positive effects. This study, published in Nature Medicine, highlights the significant impact of diet on the immune system and metabolism.
Lifestyle diseases such as cardiovascular diseases, diabetes, and chronic inflammatory conditions are surging across Africa, posing a growing challenge to healthcare systems throughout the continent. Increasing economic ...
Electrochemical method supports nitrogen circular economy
2025-04-03
By Shawn Ballard
Imagine a world where industrial waste isn’t just reduced, it’s turned into something useful. This kind of circular economy is already in the works for carbon. Now, researchers in energy, environmental & chemical engineering at Washington University in St. Louis have developed a promising pathway to convert harmful nitric oxide, a key component of acid rain, into valuable nitric acid, which is used in everyday applications from fertilizer production to metal processing.
Feng Jiao, the Lauren and Lee Fixel Distinguished Professor in the McKelvey School of Engineering at WashU, and collaborators developed a method ...
How researchers are shining a light on kidney disease
2025-04-03
For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts, dialysis and transplantation are among the only treatments.
More than 12.4 million people worldwide suffer from the dominant form of the condition. Now, Rutgers University geneticists have uncovered fresh details of how the disease progresses – findings that could open the door to new therapies.
In a study published in Nature Communications, Inna Nikonorova, a research assistant professor in the Department of Genetics within the Rutgers School of Arts and Sciences, reports on a novel way to identify and track material carried ...
Some gut bacteria could make certain drugs less effective
2025-04-03
A new study, published today in Nature Chemistry by researchers from the University of Pittsburgh and Yale University, shows how common gut bacteria can metabolize certain oral medications that target cellular receptors called GPCRs, potentially rendering these important drugs less effective.
Drugs that act on GPCRs, or G protein-coupled receptors, include more than 400 medications approved by the U.S. Food and Drug Administration (FDA) for treatment of many common conditions such as migraines, depression, type 2 diabetes, prostate cancer and more.
“Understanding how GPCR-targeted drugs interact with human gut microbiota is critical for advancing ...
PEPITEM sequence shows effects in psoriasis, comparable to steroid cream
2025-04-03
Birmingham scientists have shown that a sequence of just three amino acids may reduce the severity of psoriasis, when applied topically in an emollient cream.
The researchers, whose study is published in Pharmacological Research, identified the smallest part of a peptide (small protein) called PEPITEM, which occurs naturally in the body and regulates inflammation.
The study also showed that both PEPITEM and the three amino acid (tripeptide) sequence delivered a significant reduction in the severity of psoriasis, that is comparable to a steroid cream.
Psoriasis ...
Older teens who start vaping post-high school risk rapid progress to frequent use
2025-04-03
A new study has found that young vapers in the United States who begin using e-cigarettes after graduating from secondary/high school are likely to progress rapidly to frequent use. While US youths who start vaping during secondary/high school typically take about three years to progress to frequent use, this newly identified group of young adults who start vaping a bit later, after graduation (mean age = 20 years), tend to reach frequent use in about one year. ‘Frequent use’ is defined as using e-cigarettes on 20 or ...
Corpse flowers are threatened by spotty recordkeeping
2025-04-03
Commonly called the “corpse flower,” Amorphophallus titanum is endangered for many reasons, including habitat destruction, climate change and encroachment from invasive species.
Now, plant biologists from Northwestern University and the Chicago Botanic Garden have added a new threat to the list: incomplete historical records.
In a new study, scientists constructed the ancestry of corpse flowers living in collections at institutions and gardens around the world. They found a severe lack of consistent, standardized data. Without complete historical records, conservationists were unable to make informed decisions ...
Riding the AI wave toward rapid, precise ocean simulations
2025-04-03
AI has created a sea change in society; now, it is setting its sights on the sea itself.
Researchers at Osaka Metropolitan University have developed a machine learning-powered fluid simulation model that significantly reduces computation time without compromising accuracy. Their fast and precise technique opens up potential applications in offshore power generation, ship design and real-time ocean monitoring.
Accurately predicting fluid behavior is crucial for industries relying on wave and tidal energy, as well as for design of maritime structures and vessels. ...
Are lifetimes of big appliances really shrinking?
2025-04-03
Big appliances, like washing machines, ovens and refrigerators, are a major investment for many households. Consumers hope that these appliances will last for decades. More and more, however, people have the perception that these big-ticket items might not be lasting as long as they once did.
But when Kamila Krych looked at actual trends in product lifetimes as a part of her PhD research at the Norwegian University of Science and Technology's (NTNU) Industrial Ecology Programme, she found that wasn’t quite true.
“Despite what people think, there is no evidence that product lifetimes are decreasing,” she said. “Many people think that products have been becoming ...